Publication | Open Access
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
6.1K
Citations
32
References
2001
Year
Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
| Year | Citations | |
|---|---|---|
1986 | 13.4K | |
1985 | 13.4K | |
1995 | 2K | |
1983 | 1.7K | |
1983 | 1.7K | |
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. M P Bevilacqua, J S Pober, Gerard R. Majeau, Proceedings of the National Academy of Sciences Vascular DiseaseEndothelial CellsImmunologyPathologyImmunotherapy | 1986 | 1.1K |
2000 | 1K | |
1987 | 827 | |
1992 | 706 | |
1979 | 479 |
Page 1
Page 1